Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: https://t.co/XjQZgoAp3S Hands Off! Robots in Modern Medicine
    about 44 mins ago
  • Science funding is a mess. Could grant lotteries make it better? https://t.co/9akEDdSoVb via @voxdotcom
    about 14 hours ago
  • Researchers using a hand-held genomic sequencing device were able to identify targets for combating drug-resistant… https://t.co/5nE7VBwbBE
    about 19 hours ago
  • New post on Science and Enterprise: Portable Sequencer Identifies Drug-Resistant Bacteria https://t.co/6El4ePzZkx #Science #Business
    about 19 hours ago
  • Thank you @innerarchitect for all you do for lung health. Enjoy your weekend. https://t.co/nQRcgaZ2jH
    about 23 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Engineered Microbe Blocks Ammonia Blood Poisoning

Ammonia molecule

A genetically engineered bacterial strain is shown in tests with animals to stop ammonia poisons in the gut from reaching the blood stream, as well as be safe for humans in a clinical trial. . . . → Read More: Engineered Microbe Blocks Ammonia Blood Poisoning

Fitbit Devices Providing Precision Medicine Data

Fitbit Charge3

Wearers of Fitbit activity tracking devices now have the option of sharing their data with a large-scale precision medicine project run by National Institutes of Health. . . . → Read More: Fitbit Devices Providing Precision Medicine Data

Shutdown Delays FDA Peanut Allergy Drug Review

Closed sign

Regulatory review of a drug to prevent allergic reactions to peanuts appears to be delayed by the shutdown of some U.S. government operations. . . . → Read More: Shutdown Delays FDA Peanut Allergy Drug Review

Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Molly Shoichet

A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Start-up Funds Univ. Medical Cannabis Research

Cannabis plant

A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research

Trial Testing DNA Antibody Vaccine for Zika

Baby with microcephaly

A clinical trial is enrolling participants testing a vaccine to prevent Zika infections with synthetic DNA particles designed to produce antibodies against the virus. . . . → Read More: Trial Testing DNA Antibody Vaccine for Zika

Lilly Buys Precision Cancer Company in $8B Deal

Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal

Trial Testing Breath Detection for Cancer

Breath collection device

A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer. . . . → Read More: Trial Testing Breath Detection for Cancer

Duchenne Stem Cell Trial Halted

Stop signs graphic

A clinical trial testing stem cell treatments for symptoms of Duchenne muscular dystrophy is on hold after a patient reported a severe reaction. . . . → Read More: Duchenne Stem Cell Trial Halted

Antibiotic Prevents Staph Colonies in Newborns

Baby in NICU

Results from a clinical trial show a common antibiotic ointment can prevent dangerous staph bacteria from colonizing in vulnerable newborn infants. . . . → Read More: Antibiotic Prevents Staph Colonies in Newborns